Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenues:
Total revenues	$ 5,430	$ 6,825
Cost of revenues (exclusive of depreciation and amortization shown separately below)	5,317	6,687
Operating expenses:
Research and development	3,301	5,819
General and administrative	10,111	10,005
Depreciation and amortization	2,714	2,311
Impairment of assets	16,610	0
Total operating expenses	32,736	18,135
Loss from operations	(32,623)	(17,997)
Other income (expenses):
Investment income	1,206	1,864
Interest expenses	(48)	(117)
(Loss) gain in fair value of derivatives	(38)	296
Gain in fair value of common stock warrants liability	2,778	649
Gain in fair value of earnout liability	2,462	1,518
Other expenses, net	(119)	(8)
Total other income, net	6,241	4,202
Loss before income tax provision	(26,382)	(13,795)
Income tax provision	(59)	(118)
Net loss	(26,441)	(13,913)
Other comprehensive income (loss):
Unrealized gain on marketable securities	159	570
Foreign currency translation adjustment	236	(3,844)
Total other comprehensive income (loss)	395	(3,274)
Total comprehensive loss	$ (26,046)	$ (17,187)
Net loss per share, basic (in dollars per share)	$ (0.18)	$ (0.10)
Net loss per share, diluted (in dollars per share)	$ (0.18)	$ (0.10)
Weighted-average common shares outstanding, basic (in shares)	146,852,340	141,828,895
Weighted-average common shares outstanding, diluted (in shares)	146,852,340	141,828,895
Products
Revenues:
Total revenues	$ 5,430	$ 6,822
Services
Revenues:
Total revenues	$ 0	$ 3